메뉴 건너뛰기




Volumn 67, Issue 8, 2000, Pages 577-583

New options for untreatable coronary artery disease: Angiogenesis and laser revascularization

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; LISINOPRIL; METOPROLOL; NITRIC ACID DERIVATIVE; VASCULOTROPIN;

EID: 0033867926     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.67.8.577     Document Type: Review
Times cited : (9)

References (17)
  • 1
    • 0032842144 scopus 로고    scopus 로고
    • Direct myocardial revascularization and angiogenesis - How many patients might be eligible?
    • Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis - How many patients might be eligible? Am J Cardiol 1999; 84:598-600.
    • (1999) Am J Cardiol , vol.84 , pp. 598-600
    • Mukherjee, D.1    Bhatt, D.L.2    Roe, M.T.3    Patel, V.4    Ellis, S.G.5
  • 3
    • 0033152353 scopus 로고    scopus 로고
    • ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: Executive summary and recommendations
    • A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina)
    • Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999; 99:2829-2848.
    • (1999) Circulation , vol.99 , pp. 2829-2848
    • Gibbons, R.J.1    Chatterjee, K.2    Daley, J.3
  • 4
    • 0032562232 scopus 로고    scopus 로고
    • Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
    • Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease Circulation 1998; 97:645-650.
    • (1998) Circulation , vol.97 , pp. 645-650
    • Schumacher, B.1    Pecher, P.2    Von Specht, B.U.3    Stegmann, T.4
  • 5
    • 0031809572 scopus 로고    scopus 로고
    • Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results
    • Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 1998; 65:1540-1544.
    • (1998) Ann Thorac Surg , vol.65 , pp. 1540-1544
    • Sellke, F.W.1    Laham, R.J.2    Edelman, E.R.3    Pearlman, J.D.4    Simons, M.5
  • 7
    • 0032578961 scopus 로고    scopus 로고
    • Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
    • Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98:2800-2804.
    • (1998) Circulation , vol.98 , pp. 2800-2804
    • Losordo, D.W.1    Vale, P.R.2    Symes, J.F.3
  • 9
    • 0000438994 scopus 로고    scopus 로고
    • Double-blind, placebo controlled trial of recombinant human vascular endothelial growth factor-the VIVA trial
    • Henry TD, Annex BH, Azrin MA, et al. Double-blind, placebo controlled trial of recombinant human vascular endothelial growth factor-the VIVA trial [abstract]. J Am Coll Cardiol 1999; 33:384A.
    • (1999) J Am Coll Cardiol , vol.33
    • Henry, T.D.1    Annex, B.H.2    Azrin, M.A.3
  • 10
    • 0032542072 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis
    • Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98:2108-2116.
    • (1998) Circulation , vol.98 , pp. 2108-2116
    • Inoue, M.1    Itoh, H.2    Ueda, M.3
  • 11
    • 0342416921 scopus 로고    scopus 로고
    • Prospects for therapeutic angiogenesis and myogenesis in patients with advanced coronary disease
    • Ellis SG, Cura FA, Mukherjee D. Prospects for therapeutic angiogenesis and myogenesis in patients with advanced coronary disease. J Invasive Cardiol 1999; 11:615-617.
    • (1999) J Invasive Cardiol , vol.11 , pp. 615-617
    • Ellis, S.G.1    Cura, F.A.2    Mukherjee, D.3
  • 12
    • 0029799879 scopus 로고    scopus 로고
    • Nonfluoroscopic, in vivo navigation and mapping technology
    • Ben-Haim SA, Osadchy D, Schuster I, et al. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996; 2:1393-1395.
    • (1996) Nat Med , vol.2 , pp. 1393-1395
    • Ben-Haim, S.A.1    Osadchy, D.2    Schuster, I.3
  • 13
    • 0032989459 scopus 로고    scopus 로고
    • Transmyocardial laser revascularization in patients with refractory angina: A randomized controlled trial
    • Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet 1999; 353:519-524.
    • (1999) Lancet , vol.353 , pp. 519-524
    • Schofield, P.M.1    Sharples, L.D.2    Caine, N.3
  • 14
    • 0033619157 scopus 로고    scopus 로고
    • Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
    • Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999; 341:1021-1028.
    • (1999) N Engl J Med , vol.341 , pp. 1021-1028
    • Frazier, O.H.1    March, R.J.2    Horvath, K.A.3
  • 15
    • 0033619160 scopus 로고    scopus 로고
    • Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina
    • Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999; 341:1029-1036.
    • (1999) N Engl J Med , vol.341 , pp. 1029-1036
    • Allen, K.B.1    Dowling, R.D.2    Fudge, T.L.3
  • 16
    • 0029928186 scopus 로고    scopus 로고
    • Transmyocardial laser revascularization: Operative techniques and clinical results at two years
    • Horvath KA, Mannting F, Cummings N, Shernan SK, Conn LH. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg 1996; 111:1047-1053.
    • (1996) J Thorac Cardiovasc Surg , vol.111 , pp. 1047-1053
    • Horvath, K.A.1    Mannting, F.2    Cummings, N.3    Shernan, S.K.4    Conn, L.H.5
  • 17
    • 0029874513 scopus 로고    scopus 로고
    • Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up
    • discussion 797-799
    • Cooley DA, Frazier OH, Kadipasaoglu KA, et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg 1996; 111:791-797; discussion 797-799.
    • (1996) J Thorac Cardiovasc Surg , vol.111 , pp. 791-797
    • Cooley, D.A.1    Frazier, O.H.2    Kadipasaoglu, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.